U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Reuters01-07 16:32
U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Jan 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNX Resources, Inari Medical and Royal Gold, on Tuesday.

HIGHLIGHTS

* CNX Resources Corp CNX.N: Gerdes Energy Research raises to buy from neutral

* Excelerate Energy Inc EE.N: JP Morgan cuts to underweight from neutral

* Inari Medical Inc NARI.O: Canaccord Genuity cuts to hold from buy

* Instil Bio Inc TIL.O: Jefferies raises to buy from hold

* Royal Gold Inc RGLD.O: Jefferies raises to buy from hold

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Affiliated Managers Group Inc AMG.N: Jefferies raises target price to $216 from $207

* Ally Financial Inc ALLY.N: Truist Securities initiates coverage with buy rating; PT $42

* American Express Co AXP.N: Truist Securities initiates coverage with buy rating; PT $350

* America'S Car-Mart Inc CRMT.O: Jefferies raises target price to $51 from $45

* Arcutis Biotherapeutics Inc ARQT.O: Mizuho raises target price to $20 from $19

* Atlanticus Holdings Corp ATLC.O: Jefferies raises target price to $70 from $55

* Bank of America BAC.N: Truist Securities initiates coverage with buy rating; PT $52

* Bank of New York Mellon BK.N: Truist Securities starts coverage with buy rating; PT $91

* BlackRock BLK.N: Jefferies raises target price to $1175 from $1129

* Broadridge Financial Solutions Inc BR.N: Raymond James raises PT to $238 from $235

* Capital One Financial COF.N: Truist Securities starts coverage with buy rating; PT $229

* Charles Schwab Corp SCHW.N: Raymond James raises target price to $86 from $79

* Charles Schwab Corp SCHW.N: Truist Securities initiates coverage with buy rating; PT $86

* Citigroup C.N: Truist Securities initiates coverage with buy rating; price target $85

* Citizens Financial CFG.N: Truist Securities initiates coverage with hold rating; PT $49

* CNX Resources Corp CNX.N: Gerdes Energy Research cuts target price by $1 to $37

* CNX Resources Corp CNX.N: Gerdes Energy Research raises to buy from neutral

* Coca-Cola Co KO.N: Piper Sandler initiates coverage with overweight rating; PT $74

* Comerica Inc CMA.N: Truist Securities initiates coverage with hold rating; PT $65

* Constellation Brands Inc STZ.N: JP Morgan cuts target price to $262 from $293

* Denali Therapeutics Inc DNLI.O: JP Morgan cuts target price to $24 from $28

* Discover Financial Services DFS.N: Truist Securities starts with buy rating; PT $233

* Excelerate Energy Inc EE.N: JP Morgan cuts to underweight from neutral

* Excelerate Energy Inc EE.N: JP Morgan raises target price to $31 from $22

* Federated Hermes Inc FHI.N: Jefferies raises target price to $40 from $37

* Fedex Corp FDX.N: JP Morgan raises target price to $372 from $370

* Fifth Third Bancorp FITB.O: Truist Securities initiates coverage with buy rating; PT $51

* First Citizens Bancshares FCNCA.O: Truist Securities starts with hold rating; PT $2,303

* Franklin Resources Inc BEN.N: Jefferies raises target price to $22 from $20

* Goldman Sachs GS.N: Jefferies raises target price to $667 from $609

* Hasbro Inc HAS.O: Jefferies cuts target price to $67 from $83

* Huntington Bancshares HBAN.O: Truist Securities starts coverage with buy rating; PT $19

* Inari Medical Inc NARI.O: Canaccord Genuity cuts to hold from buy

* Inari Medical Inc NARI.O: Canaccord Genuity raises target price to $80 from $74

* Inari Medical Inc NARI.O: Leerink Partners raises target price to $80 from $52

* Inari Medical Inc NARI.O: Piper Sandler raises target price to $80 from $52

* Instil Bio Inc TIL.O: Jefferies raises target price to $52 from $11

* Instil Bio Inc TIL.O: Jefferies raises to buy from hold

* JP Morgan JPM.N: Truist Securities initiates coverage with hold rating; price target $260

* Keurig DR Pepper Inc KDP.O: Piper Sandler initiates coverage with neutral rating; PT $35

* Keycorp KEY.N: Truist Securities initiates coverage with hold rating; PT $19

* M&T Bank Corp MTB.N: Truist Securities initiates coverage with buy rating; PT $233

* Morgan Stanley MS.N: Jefferies raises target price to $144 from $135

* Northern Trust NTRS.O: Truist Securities initiates coverage with hold rating; PT $110

* Oportun Financial Corp OPRT.O: Jefferies raises target price to $4 from $3.5

* PNC Financial Services PNC.N: Truist Securities starts coverage with hold rating; PT $215

* Regions Financial RF.N: Truist Securities initiates coverage with hold rating; PT $25

* Royal Gold Inc RGLD.O: Jefferies raises target price to $178 from $154

* Royal Gold Inc RGLD.O: Jefferies raises to buy from hold

* State Street Corp STT.N: Truist Securities initiates coverage with hold rating; PT $106

* Synchrony Financial SYF.N: Truist Securities initiates coverage with hold rating; PT $72

* T Rowe price Group Inc TROW.O: Jefferies raises target price to $108 from $107

* Ulta Beauty Inc ULTA.O: Canaccord Genuity raises target price to $538 from $500

* Ulta Beauty Inc ULTA.O: Jefferies raises target price to $412 from $390

* Ulta Beauty Inc ULTA.O: Oppenheimer raises target price to $515 from $505

* Ulta Beauty Inc ULTA.O: Piper Sandler raises target price to $425 from $394

* UPS UPS.N: JP Morgan raises target price to $135 from $134

* US Bancorp USB.N: Truist Securities initiates coverage with hold rating; PT $54

* Wells Fargo & Co WFC.N: Truist Securities initiates coverage with buy rating; PT $82

* Wintrust Financial WTFC.O: Truist Securities initiates coverage with buy rating; PT $151

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment